03.07.2013 Celesio AG  DE000CLS1001

DGAP-News: Celesio AG: Changes in the Management Board of Celesio AG


 
DGAP-News: Celesio AG / Key word(s): Change of Personnel Celesio AG: Changes in the Management Board of Celesio AG 03.07.2013 / 17:23 --------------------------------------------------------------------- Changes in the Management Board of Celesio AG - Markus Pinger dismissed as Chief Executive Officer - Dr Marion Helmes spokesperson of the Board with immediate effect Stuttgart, 3 July 2013 - In a meeting of the Celesio Supervisory Board today Markus Pinger (50) has been dismissed as Chief Executive Officer and Member of the Management Board of the Celesio AG with immediate effect. The separation is due to different opinions of the management of the company. Dr Marion Helmes (47) will take over provisionally the function as spokesperson of the Management Board of the Celesio AG in addition to her function as Chief Financial Officer. 'The Celesio Supervisory Board would like to thank Markus Pinger for his work in the Management Board', says Stephan Gemkow, Chairman of the Supervisory Board. 'Dr Helmes has contributed decisively to the chosen path of the realignment of the group. The Supervisory Board is looking forward to working together with Mrs. Helmes in her extended responsibilities.' Press contact Marc Binder, Celesio AG, +49 (0)711.5001-380 [email protected] Rainer Berghausen, Celesio AG, +49 (0)711.5001-549 [email protected] About Celesio Group As a leading international trading company and provider of logistics and services in the pharmaceutical and healthcare sector, Celesio takes a proactive and preventive approach to ensuring that patients receive the products and support that they require for optimum care. With 39,000 employees, we operate in 16 countries around the world. Every day, we serve over 2 million customers - at 2,200 pharmacies of our own and 4,100 participants in our brand partnership schemes. With around 140 wholesale branches, we supply approximately 65,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products. Our services benefit a patient pool of about 15 million per day. End of Corporate News --------------------------------------------------------------------- 03.07.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Celesio AG Neckartalstr. 155 70376 Stuttgart Germany Phone: +49 (0)711 5001-735 Fax: +49 (0)711 5001-740 E-mail: [email protected] Internet: www.celesio.com ISIN: DE000CLS1001 WKN: CLS100 Indices: MDAX Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime Standard), München, Stuttgart; Freiverkehr in Hamburg, Hannover; Terminbörse EUREX End of News DGAP News-Service --------------------------------------------------------------------- 219753 03.07.2013